Dow Down0.17% Nasdaq Down0.28%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NCM
2.67 0.12(4.30%) Sep 30, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Net Income (7,015) (8,636) (6,678) (10,054)
Operating Activities, Cash Flows Provided By or Used In
Depreciation55  55  65  62  
Adjustments To Net Income401  1,721  10  348  
Changes In Accounts Receivables3,825  99  1,342  (3,478)
Changes In Liabilities509  1,051  722  2,017  
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities(687)4,018  (2,999)874  
Total Cash Flow From Operating Activities (2,912) (1,692) (7,538) (10,231)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(60)(7)(19)(9)
Investments8,923  15,707  9,198  4,416  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities 8,863   15,700   9,179   4,407  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock2,860  30   -   -  
Net Borrowings3,174   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 6,034   30   -   -  
Effect Of Exchange Rate Changes(1)(1)2  25  
Change In Cash and Cash Equivalents 11,984   14,037   1,643   (5,799)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.